Table 2. MSD analysis of cytokine (pg/ml) release from HUVEC.

Analyte (pg/ml)	GM-CSF	IFNγ	IL-10	IL-12p70	IL-1β	IL-2	IL-6	TNFα	CXCL8
CONTROL	37.0±1.6	2.8±1.0	1.4±1.2	12.9±0.9	1.3±0.6	69.3±19.2	63.7±20.4	0.5±0.3	1500.6±351.5
+ C12-iE-DAP	190.0±44.8	7.9±3.0	2.7±1.1	60.2±12.5*	7.0±3.3	198.2±26.3*	213.1±65.1	1.7±0.9	6044.1±960.3*
+ LPS	279.±115.5	5.1±1.3	4.7±0.6	38.7±5.0	5.6±2.4	223.1±34.3*	323.8±114.2	1.8±1.0	6154.4±857.6*

Data are mean ± SEM for n = 3. HUVEC were treated for 24 hours with vehicle, LPS (1 µg/ml), or C12-iE-DAP (10 µg/ml). Statistical significance was determined by one-way ANOVA followed by Dunnett's multiple comparison test (*p<0.05).